Belgian MEP proposes custom orphan drug exclusivity for innovation in untreated areas
10-03-2024
EURACTIV - Belgian MEP Frederique Ries has proposed tailoring market exclusivity periods for orphan drugs to foster innovation, advocating a 12-year exclusivity period for orphan drug indications lacking authorised medicinal products in the EU. Read more
Frederique Ries, MEP [<a href="https://multimedia.europarl.europa.eu/en/photo/envi-vote-on-pesticides-carbon-removals-glyphosate-co2_20231024_EP-158111A_AR2_294" target="_blank" rel="noopener">Alain Rolland</a>]